FilingPulse

CERO insider transaction filings

CERO THERAPEUTICS HOLDINGS, INC. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-21. Screen CERO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-04-214Francois Eric — DirectorGrant/award (A): 1,823,278 (derivative) @ $0EDGAR
2026-01-094Pierce Kristen — Chief Development OfficerGrant/award (A): 1,612,099 (derivative) @ $0EDGAR
2026-01-094KUCHARCHUK ANDREW ALBERT — Chief Financial OfficerGrant/award (A): 1,162,099 (derivative) @ $0EDGAR
2026-01-094Rolfe Lindsey — DirectorGrant/award (A): 690,900 (derivative) @ $0EDGAR
2026-01-094Byrnes Michael — DirectorGrant/award (A): 690,900 (derivative) @ $0EDGAR
2026-01-094Patel Shami — DirectorGrant/award (A): 690,900 (derivative) @ $0EDGAR
2026-01-094Ehrlich Christopher B — Chairman and CEO, DirectorGrant/award (A): 4,530,997 (derivative) @ $0EDGAR
2026-01-094ATWOOD BRIAN G — DirectorGrant/award (A): 1,612,099 (derivative) @ $0EDGAR
2026-01-094LAPORTE KATHLEEN — DirectorGrant/award (A): 690,900 (derivative) @ $0EDGAR
2025-06-024Pierce Kristen — Chief Development OfficerGrant/award (A): 154,841 (derivative) @ $0EDGAR
2025-06-024KUCHARCHUK ANDREW ALBERT — Chief Financial OfficerGrant/award (A): 152,500 (derivative) @ $0EDGAR
2025-06-024Rolfe Lindsey — DirectorGrant/award (A): 9,326 (derivative) @ $0EDGAR
2025-06-024Byrnes Michael — DirectorGrant/award (A): 9,326 (derivative) @ $0EDGAR
2025-06-024Patel Shami — DirectorGrant/award (A): 11,693 (derivative) @ $0EDGAR
2025-06-024Ehrlich Christopher B — Chairman and CEO, DirectorGrant/award (A): 61,843 (derivative) @ $0EDGAR
2025-06-024ATWOOD BRIAN G — DirectorGrant/award (A): 122,549 (derivative) @ $0EDGAR
2025-06-024LAPORTE KATHLEEN — DirectorGrant/award (A): 9,326 (derivative) @ $0EDGAR
2025-04-044ATWOOD BRIAN G — DirectorOption exercise (M): 294,460 @ $0.00 · Option exercise (M): 294,460 (derivative) @ $0.00EDGAR
2025-03-064Rolfe Lindsey — DirectorGrant/award (A): 17,923 (derivative) @ $0EDGAR
2025-03-064Byrnes Michael — DirectorGrant/award (A): 17,923 (derivative) @ $0EDGAR
2025-03-064Patel Shami — DirectorGrant/award (A): 14,936 (derivative) @ $0EDGAR
2025-03-064Ehrlich Christopher B — Chairman and CEO, DirectorGrant/award (A): 119,486 (derivative) @ $0EDGAR
2025-03-064ATWOOD BRIAN G — DirectorGrant/award (A): 14,936 (derivative) @ $0EDGAR
2025-03-064LAPORTE KATHLEEN — DirectorGrant/award (A): 17,923 (derivative) @ $0EDGAR
2025-02-264Rolfe Lindsey — DirectorGrant/award (A): 127,500 (derivative) @ $0EDGAR
2025-02-264Byrnes Michael — DirectorGrant/award (A): 127,500 (derivative) @ $0EDGAR
2025-02-264Patel Shami — DirectorGrant/award (A): 127,500 (derivative) @ $0EDGAR
2025-02-264Ehrlich Christopher B — Chairman and CEO, DirectorGrant/award (A): 1,275,000 (derivative) @ $0EDGAR
2025-02-264ATWOOD BRIAN G — DirectorGrant/award (A): 254,000 (derivative) @ $0EDGAR
2025-02-264LAPORTE KATHLEEN — DirectorGrant/award (A): 127,500 (derivative) @ $0EDGAR
2025-02-074ATWOOD BRIAN G — DirectorGrant/award (A): 306,120 (derivative) @ $0.00 · Grant/award (A): 204,080 (derivative) @ $0.00 · Grant/award (A): 306,120 (derivative) @ $1.96 · Grant/award (A): 204,080 (derivative) @ $1.96EDGAR

Recent 8-K events — CERO THERAPEUTICS HOLDINGS, INC.

FiledFormItems reportedSource
2026-07-178-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-268-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-298-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-018-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-148-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-118-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-02-138-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
4.01 — Changes in Registrant's Certifying Accountant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
2026-02-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-02-038-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-01-078-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CERO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →